Cliff Asness's TNXP Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 20,020 shares of Tonix Pharmaceuticals Holding Corp. (TNXP) worth $312,713, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in TNXP, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Tonix Pharmaceuticals Holding (TNXP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tonix Pharmaceuticals Holding (TNXP) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +20,020 | New Buy | 20,020 | $15.62 |
Cliff Asness's Tonix Pharmaceuticals Holding Investment FAQs
Cliff Asness first purchased Tonix Pharmaceuticals Holding Corp. (TNXP) in Q4 2025, acquiring 20,020 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Tonix Pharmaceuticals Holding Corp. (TNXP) for 1 quarters since Q4 2025.
Cliff Asness's largest addition to Tonix Pharmaceuticals Holding Corp. (TNXP) was in Q4 2025, adding 20,020 shares worth $312,713.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 20,020 shares of Tonix Pharmaceuticals Holding Corp. (TNXP), valued at approximately $312,713.
As of the Q4 2025 filing, Tonix Pharmaceuticals Holding Corp. (TNXP) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Tonix Pharmaceuticals Holding Corp. (TNXP) was 20,020 shares, as reported at the end of Q4 2025.